Figure 1

Changes in plasma aldosterone (ALD) levels for 18 months. Closed columns represent patients who received efonidipine (Efo) replaced by amlodipine (Aml), open columns represent patients who continued amlodipine. ^*P<0.01 vs. the baseline value by analysis of variance with Scheffe's test.